4.7 Article

Compartmental and COMSOL Multiphysics 3D Modeling of Drug Diffusion to the Vitreous Following the Administration of a Sustained-Release Drug Delivery System

Journal

PHARMACEUTICS
Volume 13, Issue 11, Pages -

Publisher

MDPI
DOI: 10.3390/pharmaceutics13111862

Keywords

targeted drug delivery; ocular drug delivery; compartmental modeling; pharmacokinetic modeling; COMSOL 3D modeling; hydrogels; topical delivery; subconjunctival delivery; intravitreal delivery; subretinal delivery

Funding

  1. Rose-Hulman Institute of Technology, Independent Project/Research Opportunities Program (IPROP)
  2. Rose-Hulman Summer undergraduate Research Fellowships program (R-SURF)

Ask authors/readers for more resources

This study utilized computational and 3D models to investigate antibiotic drug transport from a hydrogel drug delivery system to the eye. Different routes of drug administration showed varying times to reach peak concentrations in the vitreous, but all successfully achieved therapeutic levels. These models could potentially be used to optimize drug loading doses in the delivery system to minimize drug use and waste.
The purpose of this study was to examine antibiotic drug transport from a hydrogel drug delivery system (DDS) using a computational model and a 3D model of the eye. Hydrogel DDSs loaded with vancomycin (VAN) were synthesized and release behavior was characterized in vitro. Four different compartmental and four COMSOL models of the eye were developed to describe transport into the vitreous originating from a DDS placed topically, in the subconjunctiva, subretinally, and intravitreally. The concentration of the simulated DDS was assumed to be the initial concentration of the hydrogel DDS. The simulation was executed over 1500 and 100 h for the compartmental and COMSOL models, respectively. Based on the MATLAB model, topical, subconjunctival, subretinal and vitreous administration took most (~500 h to least (0 h) amount of time to reach peak concentrations in the vitreous, respectively. All routes successfully achieved therapeutic levels of drug (0.007 mg/mL) in the vitreous. These models predict the relative build-up of drug in the vitreous following DDS administration in four different points of origin in the eye. Our model may eventually be used to explore the minimum loading dose of drug required in our DDS leading to reduced drug use and waste.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available